The Budget Impact of Introducing Bg-12 (Dimethyl Fumarate) for Treatment of Relapse-Remitting Multiple Sclerosis (RRMS) in Canada
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1812
https://www.valueinhealthjournal.com/article/S1098-3015(13)03717-0/fulltext
Title :
The Budget Impact of Introducing Bg-12 (Dimethyl Fumarate) for Treatment of Relapse-Remitting Multiple Sclerosis (RRMS) in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03717-0&doi=10.1016/j.jval.2013.08.1812
First page :
A620
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1651